ftInvstr
SPARC · Healthcare ₹210.8 +6.99% Mkt Cap ₹6942 Cr

SPARC

Healthcare Drug Manufacturers - Specialty & Generic
₹210.8
+6.99% today · 30d +12.79%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for SPARC. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹30 Cr
+282.06% YoY
NET PROFIT
₹-24 Cr
OPM
-40.99%
+793.95pp YoY
EPS
₹-0.75
PE 4.18
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-3.8% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
SPARC4.18164.0
SUNPHARMA37.7921.44
DIVISLAB93.121.56
ZYDUSLIFE28.424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
71
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation CHEAP 90
Growth STRONG 74
Profitability DECENT 52
Technicals NEUTRAL 58
Risk MODERATE 50
Key Stats
TTM PE
4.18
P/B
4.75
52W HIGH
₹289.0
OFF HIGH
-27.06%
DIV YIELD
0.0%
MKT CAP
₹6942 Cr
◉ Active Signals
MACDBullish3.6263
RSI(14)Bullish66.83
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SPARC and at what entry.

Sign up freeSign in